| Symbol |
OPA1 |
| Full Name |
Optic Atrophy 1 |
| Aliases |
MTOA, ATL3 (related), KIAA0057 |
| Chromosome |
3q29 |
| NCBI Gene ID |
4976 |
| UniProt ID |
O60313 |
| Protein |
[OPA1 protein](/proteins/opa1-protein) |
OPA1 (Optic Atrophy 1) encodes a dynamin-related GTPase localized to the inner mitochondrial membrane. It is essential for mitochondrial inner membrane fusion, cristae maintenance, and mitochondrial DNA (mtDNA) nucleoid organization. Mutations in OPA1 cause autosomal dominant optic atrophy (ADOA), the most common inherited optic neuropathy, and are associated with broader neurodegenerative phenotypes including hearing loss, peripheral neuropathy, and movement disorders including Parkinson's disease[^khanno2021].
OPA1 is a nuclear-encoded mitochondrial protein that functions as a large GTPase mediating mitochondrial inner membrane fusion. The protein contains multiple functional domains:
- N-terminal GTPase domain: Catalyzes GTP hydrolysis for membrane fusion
- Middle domain: Mediates oligomerization
- GTPase effector domain (GED): Regulates GTPase activity and fusion
OPA1 exists in long isoforms (L-OPA1) that mediate fusion and short isoforms (S-OPA1) generated by proteolytic cleavage that promote mitochondrial fission. The balance between OPA1-mediated fusion and DRP1-mediated fission maintains mitochondrial dynamics essential for neuronal survival[^alexander2000].
- Mitochondrial inner membrane fusion: OPA1 is the primary mediator of inner membrane fusion, working with OPA3 and mitofusins (MFN1/2) for outer membrane fusion
- Cristae remodeling: OPA1 maintains cristae structure and prevents cytochrome c release during apoptosis
- mtDNA maintenance: OPA1 associates with mtDNA nucleoids and is required for mtDNA replication and transcription
- Respiratory chain assembly: OPA1 deficiency impairs complex I assembly and respiratory function
Multiple lines of evidence connect OPA1 dysfunction to PD pathogenesis:
- Mitochondrial dysfunction: OPA1 mutations impair mitochondrial respiration and ATP production, critical in dopaminergic neuron survival
- PINK1/Parkin pathway: OPA1 is downregulated during PINK1/Parkin-mediated mitophagy; OPA1 cleavage is required for mitochondrial quality control
- alpha-synuclein toxicity: OPA1 deficiency exacerbates alpha-synuclein-induced mitochondrial dysfunction
- Clinical overlap: Some OPA1 mutation carriers develop parkinsonism alongside optic atrophy
- OPA1 expression is reduced in AD brain tissue
- Mitochondrial fragmentation and cristae loss in AD neurons involve OPA1 dysfunction
- OPA1 deficiency may contribute to amyloid-beta-induced mitochondrial pathology
- Huntington's disease: OPA1 cleavage and mitochondrial fragmentation observed in HD models
- Amyotrophic lateral sclerosis (ALS): OPA1 mutations and mitochondrial defects in some ALS cases
- Charcot-Marie-Tooth disease: OPA1 related to CMT2A phenotype
OPA1-mediated fusion competes with DRP1-mediated fission. In neurodegeneration:
- OPA1 cleavage by OMA1 produces excessive S-OPA1
- This shifts the balance toward fission
- Resulting mitochondrial fragmentation impairs quality control
- Fragmented mitochondria accumulate dysfunctional respiratory complexes
OPA1 mutations cause mtDNA copy number reduction and deletion accumulation:
- Impaired mtDNA replication and nucleoid maintenance
- Accumulation of deleterious mtDNA mutations
- Particularly affect high-energy neurons (dopaminergic, retinal ganglion cells)
Loss of OPA1 function sensitizes neurons to apoptotic stimuli:
- Impaired cristae structure promotes cytochrome c release
- Loss of inner membrane integrity
- Enhanced caspase activation cascade
- Mitochondrial fusion promoters: Current research seeks to identify OPA1 activators
- Antioxidants: Mitigate oxidative stress from mitochondrial dysfunction
- mTOR inhibitors: Promote autophagy to clear defective mitochondria
- AAV-mediated OPA1 overexpression shows promise in preclinical models
- CRISPR approaches to correct pathogenic OPA1 variants under investigation
- OPA1 levels in cerebrospinal fluid may serve as mitochondrial health marker
- Skin fibroblasts from OPA1 mutation carriers show diagnostic changes
| Partner |
Interaction Type |
Functional Consequence |
| MFN1/MFN2 |
Co-fusion |
Outer membrane fusion |
| OMA1 |
Proteolytic regulation |
OPA1 cleavage to S-OPA1 |
| DRP1 |
Balance |
Fusion/fission dynamics |
| mtDNA |
Nucleoid binding |
mtDNA maintenance |
| Complex I |
Assembly |
Respiratory chain function |